Bemarituzumab FIGHTs Gastric/GEJ Cancers, Improving Survival ...Middle East

Medscape - News
Adding bemarituzumab to chemotherapy as first-line treatment for advanced gastric and gastroesophageal junction (GEJ) cancers improved survival over chemotherapy alone in the phase 2 FIGHT trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Bemarituzumab FIGHTs Gastric/GEJ Cancers, Improving Survival )

Apple Storegoogle play

Also on site :